LIFEMD, INC. (LFMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 46.61M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 11.26M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 2.96M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $46.61M | (m) | (m) | $11.26M | $2.96M | (m) |
| 2026-03-31 | (m) | $49.59M | (m) | (m) | $9.86M | $3.18M | (m) |
| 2025-12-31 | (m) | $41.57M | (m) | (m) | $9.31M | $2.77M | (m) |
| 2025-09-30 | (m) | $56.66M | (m) | (m) | $9.24M | $3.43M | (m) |
| 2025-06-30 | (m) | $63.53M | $36.23M | (m) | $7.33M | $3.25M | (m) |
| 2025-03-31 | (m) | $60.90M | $34.39M | (m) | $10.19M | $2.97M | (m) |
| 2024-12-31 | (m) | $60.26M | $35.00M | (m) | $8.22M | $2.80M | (m) |
| 2024-09-30 | (m) | $58.95M | $37.59M | (m) | $6.05M | $2.65M | (m) |
| 2024-06-30 | (m) | $51.65M | $35.70M | (m) | $5.67M | $2.06M | (m) |
| 2024-03-31 | (m) | $44.68M | $35.11M | (m) | $5.34M | $2.37M | (m) |
| 2023-12-31 | (m) | $34.78M | $33.15M | (m) | $5.28M | $2.76M | (m) |
| 2023-09-30 | (m) | $32.52M | $15.29M | (m) | $4.42M | $3.79M | (m) |
| 2023-06-30 | (m) | $31.52M | $11.91M | (m) | $3.67M | $3.70M | (m) |
| 2023-03-31 | (m) | $27.02M | $11.52M | (m) | $2.94M | $3.38M | (m) |
| 2022-12-31 | (m) | $31.37M | $3.96M | (m) | $2.83M | $3.70M | (m) |
| 2022-09-30 | (m) | $24.94M | $5.84M | (m) | $2.54M | $3.68M | (m) |
| 2022-06-30 | (m) | $25.87M | $11.72M | (m) | $2.51M | $2.97M | (m) |
| 2022-03-31 | (m) | $25.61M | $25.08M | (m) | $1.80M | $1.24M | (m) |
| 2021-12-31 | (m) | $22.83M | $41.33M | (m) | $980.05K | $1.62M | (m) |
| 2021-09-30 | (m) | $19.88M | $9.45M | (m) | $1.50M | $1.59M | (m) |
| 2021-06-30 | (m) | $18.55M | $17.41M | (m) | $1.61M | $1.61M | (m) |
| 2021-03-31 | (m) | $15.44M | $13.41M | (m) | $1.35M | $1.67M | (m) |
| 2020-12-31 | (m) | $13.49M | $9.18M | (m) | $648.42K | $1.26M | (m) |
| 2020-09-30 | (m) | $9.44M | $916.64K | (m) | $414.34K | $1.86M | (m) |
| 2020-06-30 | (m) | $7.16M | $336.15K | (m) | $436.02K | $808.85K | (m) |
| 2020-03-31 | (m) | $4.64M | $357.88K | (m) | $282.48K | $554.28K | (m) |
| 2019-12-31 | (m) | $3.98M | $1.11M | (m) | $97.45K | $950.06K | (m) |
| 2019-09-30 | (m) | $2.98M | $780.89K | (m) | $65.25K | $747.52K | (m) |
| 2019-06-30 | (m) | $2.35M | $265.11K | (m) | $103.27K | $703.29K | (m) |
| 2019-03-31 | (m) | $2.27M | $242.26K | (m) | $433.20K | $877.15K | (m) |
| 2018-12-31 | (m) | $1.19M | $180.09K | (m) | $99.05K | $1.02M | (m) |
| 2018-09-30 | (m) | $699.88K | $407.27K | (m) | $175.63K | $623.45K | (m) |
| 2018-06-30 | (m) | $511.47K | $691.17K | (m) | $64.05K | $507.21K | (m) |
| 2018-03-31 | (m) | $318.40K | $229.83K | (m) | $85.80K | $601.17K | (m) |
| 2017-12-31 | (m) | $640.97K | $141.38K | (m) | $398.77K | $707.16K | (m) |
| 2017-09-30 | (m) | $776.98K | $562.76K | (m) | $276.99K | $377.80K | (m) |
| 2017-06-30 | (m) | $1.59M | $436.09K | (m) | $519.62K | $127.45K | (m) |
| 2017-03-31 | (m) | $2.40M | $381.06K | (m) | $555.71K | $136.94K | (m) |
| 2017-01-01 | (m) | (m) | $182.56K | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.15M | $182.56K | (m) | $444.74K | $160.27K | (m) |
| 2016-09-30 | (m) | $622.31K | $473.92K | (m) | $474.92K | $130.53K | (m) |
| 2016-06-30 | (m) | $521.64K | $235.45K | (m) | $451.07K | $179.25K | (m) |
| 2016-03-31 | (m) | $436.96K | $203.62K | (m) | $299.34K | $138.49K | (m) |
| 2015-12-31 | (m) | $267.48K | $232.98K | (m) | $154.44K | $61.05K | (m) |
| 2015-09-30 | (m) | $381.86K | $73.86K | (m) | $131.72K | $39.43K | (m) |
| 2015-06-30 | (m) | $412.67K | $79.55K | (m) | $135.32K | $21.48K | (m) |
| 2015-03-31 | (m) | $343.40K | $70.05K | (m) | $73.45K | $43.46K | (m) |
| 2014-12-31 | (m) | $301.52K | $75.50K | (m) | $14.97K | $41.01K | (m) |
| 2014-09-30 | (m) | $326.34K | $90.00K | (m) | $110.62K | $54.87K | (m) |
| 2014-06-30 | (m) | $265.82K | $61.15K | (m) | $85.27K | $83.52K | (m) |
| 2014-03-31 | (m) | $218.89K | $36.41K | (m) | $116.58K | $88.06K | (m) |
| 2013-12-31 | (m) | $325.56K | $155.06K | (m) | $77.47K | $86.19K | (m) |
| 2013-09-30 | (m) | $217.48K | $46.65K | (m) | $11.31K | $120.05K | (m) |
| 2013-06-30 | (m) | (m) | $111.06K | (m) | $157.51K | $64.05K | (m) |
| 2013-03-31 | (m) | (m) | $38.92K | (m) | $113.84K | $68.78K | (m) |
| 2012-12-31 | (m) | (m) | $98.93K | (m) | $49.69K | $63.38K | (m) |
| 2012-09-30 | (m) | (m) | $163.18K | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $247.28K | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | $7.28K | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $33.50K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |